Metronidazole benzoate price December 2025 and outlook (see chart below)
- India:US$10.49/KG, -0.5% down
Business Analytiq assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, or timeliness.
NEED A QUICK DOWNLOAD?
ACCESS TO OUR FULL DATABASE IS US$399/YEAR, WITH A 30-DAY $50 TRIAL
GET THAT DOWNLOAD IN 3 MINUTES!
BusinessAnalytiq provides a database of hundreds of market & price trend data, as well as online tools to set up benchmarks and leading indicators.
Metronidazole benzoate price index
This post is a summary of the Metronidazole benzoate price developments. The price developments of Metronidazole benzoate are expressed in US$ prices converted FX rates applicable at the time when the price was valid. Metronidazole benzoate price index developments are calculated from multiple separate sources of data to ensure statistical accuracy.
The outlook for Metronidazole benzoate prices is generated from different inputs including:
- Very recent price developments of immediate cost drivers of Metronidazole benzoate prices
- Recent price developments of underlying feedstocks which drive the price of Metronidazole benzoate
- Market futures for both cost drives and feedstocks of Metronidazole benzoate prices
- Adjustment of current supply/demand imbalances in the Metronidazole benzoate market
- Longer term trends in likely demand conditions
What is Metronidazole benzoate and what is it used for
Metronidazole benzoate is the benzoate‑ester form of Metronidazole (i.e., the hydroxy group of metronidazole is esterified with benzoic acid). It belongs to the nitroimidazole family of antimicrobial agents, with both antiprotozoal and antibacterial activity. It is used in formulations (including suspensions) to treat infections caused by anaerobic bacteria and certain protozoa or intestinal parasites. For example, it may be used in oral suspension form for bacterial and intestinal‑parasite infections.
How is Metronidazole benzoate (used / administered)
Metronidazole benzoate is typically administered orally (for example as a suspension in paediatric or veterinary applications) and functions as a pro‑drug or ester derivative of metronidazole, designed to deliver the active moiety in the body. After ingestion, it is converted to metronidazole (or exerts the effect of the parent drug) and exerts its action against anaerobic bacteria or protozoa by disrupting nucleic acid synthesis. Use of the benzoate ester may support improved formulation (for example taste, suspension stability) especially in paediatric or veterinary contexts.
How large is the global market for Metronidazole benzoate and where is it produced
Estimates for the global market for metronidazole benzoate vary by source. One market report valued the global market at approximately **USD 381.7 million in 2021**, projecting growth to about **USD 465.7 million by 2025** at a CAGR of ~5.1 %. Another source estimates a 2023 value around **USD 1.06 billion**, with an expectation of about **USD 1.92 billion by 2033**, and a CAGR of ~6.12 %. Regarding production, metronidazole benzoate is manufactured by API (active pharmaceutical ingredient) suppliers in major pharmaceutical‑chemical manufacturing countries including China and India. For example, one Chinese company, Hubei Hongyuan Pharmaceutical Technology Co., Ltd., lists metronidazole benzoate as a product. Similarly, Indian suppliers are listed for the API manufacture/export. Thus production is global, with significant API manufacture in Asia and global supply from generic‑pharma regions.